// App-Quantinova.ai

OP0055 (2021) : ULTRASOUND HALO SIGN AS A POTENTIAL MONITORING TOOL FOR PATIENTS WITH GIANT CELL ARTERITIS: A PROSPECTIVE ANALYSIS

Researchers

Presenter

  • C. Ponte

Principal Investigators

  • S. Monti

  • C. A. Scir

  • P. Delvino

  • N. Khmelinskii

  • A. Milanesi

  • V. Teixeira

  • F. Brandolino

  • C. Montecucco

  • J. E. Fonseca

  • W. A. Schmidt

  • R. Luqmani

Medical Centers

  • Hospital de Santa Maria - Centro Hospitalar Universitário Lisboa Norte, Department of Rheumatology, Lisboa, Portugal

  • Instituto de Medicina Molecular (IMM), Rheumatology Research Unit, Lisbon, Portugal

  • Fondazione I.R.C.C.S. Policlinico San Matteo, Department of Rheumatology, Pavia, Italy

  • University of Pavia, PhD in Experimental Medicine, Pavia, Italy

  • Italian Society for Rheumatology (Sir), Epidemiology Unit, Milan, Italy

  • University of Verona, Rheumatology Unit, Department of Medicine, Verona, Italy

  • Centro Hospitalar e Universitário de S. João, Department of Pathology, Porto, Portugal

  • Immanuel Krankenhaus Berlin, Medical Center for Rheumatology Berlin-Buch, Berlin, Germany

  • Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford, United Kingdom

Locations

  • Portugal

  • Italy

  • Germany

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Cardiovascular (CVS)

Disease

  • Giant cell arteritis

Biomarkers

  • C reactive protein

  • Estrogen receptor alpha

Drug/Treatment

  • Prednisolone

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved